IMUX
Immunic, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.72
−0.31%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-1.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 10, 2026 | Ridloff Elena · director | A-Award | 50,740 | $15 |
| Jul 7, 2026 | Rudick Richard Alan · director | A-Award | 25,370 | $15 |
| Jul 7, 2026 | Skerjanec Simona · director | A-Award | 25,370 | $15 |
| Jul 7, 2026 | PHILLIPS BARCLAY A · director | A-Award | 25,370 | $15 |
| Jul 7, 2026 | Congleton Jon · director | A-Award | 25,370 | $15 |
| Jul 7, 2026 | Neermann Joerg · director | A-Award | 25,370 | $15 |
| Jun 29, 2026 | Whaley Glenn · officer: Chief Financial Officer | A-Award | 120,000 | $12 |
| Jun 29, 2026 | PHILLIPS BARCLAY A · director | A-Award | 25,370 | $11 |
| Jun 29, 2026 | Neermann Joerg · director | A-Award | 25,370 | $11 |
| Jun 29, 2026 | HOWSON TAMAR D · director | A-Award | 25,370 | $11 |
| Jun 29, 2026 | Rudick Richard Alan · director | A-Award | 25,370 | $11 |
| Jun 29, 2026 | Skerjanec Simona · director | A-Award | 25,370 | $11 |
| Jun 29, 2026 | Congleton Jon · director | A-Award | 50,740 | $11 |
| Jun 29, 2026 | BONNEY MICHAEL W · director | A-Award | 100,000 | $12 |
| Jun 29, 2026 | Vitt Daniel · director | A-Award | 445,000 | $12 |
| Jun 29, 2026 | Tardio Jason · officer: President and COO | A-Award | 253,000 | $12 |
| Jun 1, 2026 | Lundgren Erik · officer: Chief Executive Officer | A-Award | 1,000,000 | $13 |
| Apr 29, 2026 | Panzara Michael A. · officer: Chief Medical Officer | A-Award | 300,000 | $8.80 |
| Jul 18, 2025 | Tardio Jason · officer: President and COO | A-Award | 330,000 | $0.77 |
| Jul 18, 2025 | Whaley Glenn · officer: Chief Financial Officer | A-Award | 560,000 | $0.77 |
| Jul 18, 2025 | Whaley Glenn · officer: Chief Financial Officer | A-Award | 280,000 | $0.77 |
| Jul 18, 2025 | Nash Duane · director, officer: Executive Chairman | A-Award | 630,000 | $0.77 |
| Jul 18, 2025 | Nash Duane · director, officer: Executive Chairman | A-Award | 315,000 | $0.77 |
| Jul 18, 2025 | Vitt Daniel · director, officer: CEO and Director | A-Award | 1,720,000 | $0.77 |
| Jul 18, 2025 | Vitt Daniel · director, officer: CEO and Director | A-Award | 860,000 | $0.77 |
| Jul 18, 2025 | Muehler Andreas · officer: Chief Medical Officer | A-Award | 330,000 | $0.77 |
| Jul 18, 2025 | Muehler Andreas · officer: Chief Medical Officer | A-Award | 660,000 | $0.77 |
| Jul 18, 2025 | Tardio Jason · officer: President and COO | A-Award | 660,000 | $0.77 |
| Jun 20, 2025 | Vitt Daniel · director, officer: CEO and Director | A-Award | 1,558,000 | $0.77 |
| Jun 20, 2025 | Muehler Andreas · officer: Chief Medical Officer | A-Award | 598,500 | $0.77 |
Institutional positioning
13F filings over the trailing two quarters
New 47Increased 19Reduced 51Sold out 33
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ABRDN PLC | Unchanged | 8,243,941 | Apr 29, 2026 |
| BVF INC/IL | Unchanged | 7,652,972 | May 15, 2026 |
| AVIDITY PARTNERS MANAGEMENT LP | Increased | 6,699,411 | May 28, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 5,138,316 | May 15, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | New Position | 4,500,000 | May 14, 2026 |
| LAURION CAPITAL MANAGEMENT LP | Reduced | 3,882,162 | May 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 3,779,922 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 3,288,540 | May 15, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | Reduced | 2,506,491 | May 15, 2026 |
| 683 CAPITAL MANAGEMENT, LLC | New Position | 2,450,000 | May 15, 2026 |
| PROPEL BIO MANAGEMENT, LLC | New Position | 2,344,779 | May 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 1,525,769 | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Unchanged | 1,398,600 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 1,103,556 | May 15, 2026 |
| WOODLINE PARTNERS LP | New Position | 967,152 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 10, 2026